Experts Shape French Bioethics Policy

PARIS—The recent decision by the French government to ban for three years any genetic manipulation of the human embryo within the country's leading research centers follows a recommendation from its own expert committee on bioethical questions. The ability to shape public policy has been a hallmark of the committee since it was formed in 1983. Its report, denouncing a "zeal to procreate" among some segments of society, warned that current advances in genetics could be exploited in eugenics

Written byJacques Richardson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The ability to shape public policy has been a hallmark of the committee since it was formed in 1983. Its report, denouncing a "zeal to procreate" among some segments of society, warned that current advances in genetics could be exploited in eugenics. The moratorium, which covers researchers in all federal facilities, is meant to allow time for more permanent guidelines to be drawn up. It applies to any work that is meant to alter the genes, chromosomes or sex of embryos in vitro.

The Comité Consultatif National d'Ethique pour les Sciences de la Vie et de la Santé (National Advisory Commission on Ethics in the Life and Health Sciences) was created by President François Mitterand. Its chairman is Jean Bernard, the eminent hematologist and member of the Académie Française. The 79-year-old Bernard, author of a major work on the geographic distribution of blood problems, reports to Mitterand once a year. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies